These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2962646)

  • 21. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH; Gwirtsman HE; George DT; Ebert MH; Jimerson DC; Tomai TP; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.
    Suda T; Tozawa F; Mouri T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):225-6. PubMed ID: 6602142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone.
    Holsboer F; Gerken A; von Bardeleben U; Grimm W; Beyer H; Müller OA; Stalla GK
    Biol Psychiatry; 1986 Jun; 21(7):601-11. PubMed ID: 3011129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD; Loosen PT; Orth DN
    Biol Psychiatry; 1997 Aug; 42(3):165-74. PubMed ID: 9232208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism.
    Roy A; DeJong J; Gold P; Rubinow D; Adinoff B; Ravitz B; Waxman R; Linnoila M
    Acta Psychiatr Scand; 1990 Jul; 82(1):44-8. PubMed ID: 1975969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients.
    Hedner J; Hedner T; Lundell KH; Bissette G; O'Connor L; Nemeroff CB
    Biol Neonate; 1989; 55(4-5):260-7. PubMed ID: 2785819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of immunoreactive CSF TRH in depressed patients.
    Banki CM; Bissette G; Arato M; Nemeroff CB
    Am J Psychiatry; 1988 Dec; 145(12):1526-31. PubMed ID: 3143269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.
    Carpenter LL; Tyrka AR; McDougle CJ; Malison RT; Owens MJ; Nemeroff CB; Price LH
    Neuropsychopharmacology; 2004 Apr; 29(4):777-84. PubMed ID: 14702025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF corticotropin-releasing factor is not affected in panic disorder.
    Jolkkonen J; Lepola U; Bissette G; Nemeroff C; Riekkinen P
    Biol Psychiatry; 1993 Jan; 33(2):136-8. PubMed ID: 8439604
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
    Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M
    J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.
    Garakani A; Martinez JM; Yehuda R; Gorman JM
    J Affect Disord; 2013 Apr; 146(2):262-5. PubMed ID: 22840611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings.
    Roy A; Wolkowitz OM; Bissette G; Nemeroff CB
    Am J Psychiatry; 1994 Apr; 151(4):600-2. PubMed ID: 7511876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No acute suppression of cerebrospinal fluid corticotropin-releasing hormone in man by cortisol administration.
    Kellner M; Salzwedel C; Wortmann V; Urbanowicz T; Boelmans K; Yassouridis A; Stalla GK; Wiedemann K
    Psychiatry Res; 2013 Dec; 210(2):662-4. PubMed ID: 23896353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test.
    Galard R; Catalán R; Castellanos JM; Gallart JM
    Biol Psychiatry; 2002 Mar; 51(6):463-8. PubMed ID: 11922880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma corticotropin-releasing factor in depressive disorders.
    Catalán R; Gallart JM; Castellanos JM; Galard R
    Biol Psychiatry; 1998 Jul; 44(1):15-20. PubMed ID: 9646879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.
    Nikisch G; Agren H; Eap CB; Czernik A; Baumann P; Mathé AA
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):403-10. PubMed ID: 15784158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].
    Heinz A; Jones DW; Bissette G; Hommer D; Ragan P; Knable M; Wellek S; Linnoila M; Weinberger DR
    Pharmacopsychiatry; 2002 Jul; 35(4):127-34. PubMed ID: 12163982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults.
    Tyrka AR; Carpenter LL; McDougle CJ; Kirwin PD; Owens MJ; Nemeroff CB; Strong DR; Price LH
    Biol Psychiatry; 2004 Oct; 56(7):531-4. PubMed ID: 15450791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression.
    Holsboer F; Von Bardeleben U; Gerken A; Stalla GK; Müller OA
    N Engl J Med; 1984 Oct; 311(17):1127. PubMed ID: 6090905
    [No Abstract]   [Full Text] [Related]  

  • 40. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.
    Risch SC; Lewine RJ; Kalin NH; Jewart RD; Risby ED; Caudle JM; Stipetic M; Turner J; Eccard MB; Pollard WE
    Neuropsychopharmacology; 1992 Feb; 6(2):95-100. PubMed ID: 1319168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.